Pill Identifier App

850 ANDRX 675 (Metformin 850 mg)

Pill imprint 850 ANDRX 675 has been identified as Metformin hydrochloride 850 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 850 ANDRX 675

Metformin hydrochloride 850 mg 850 ANDRX 675
Metformin hydrochloride 850 mg 850 ANDRX 675
Metformin hydrochloride
Imprint:
850
ANDRX 675
Strength:
850 mg
Color:
White
Size:
13.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
62037-0675
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
povidone
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55045-2905 Dispensing Solutions Inc. (repackager)
53002-1422 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)